PEPENDIUM LABS

Free research / Source-linked guides

Peptide study guides

Find a peptide, see who or what was studied, what was measured, and how the experiment was structured. Human studies and preclinical research are labeled separately.

Start typing to see peptide suggestions. Every name below has a research-search route; a checked source-method guide is available only where labeled.

← Browse all study guides

These guides report individual source methods and findings. They are not standardized or personal-use dosing protocols. A preclinical study does not establish a human regimen; original source records may change.

1 checked guide shown for Tesamorelin. This is a bounded sample, not a complete peptide catalog. Search research on any peptide.

Human study

Tesamorelin

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Evidence sourceTrial registry · NCT00608023
Studied inParticipants with HIV-associated lipodystrophy; 263 enrolled
DesignPhase 3 extension with active and placebo periods
Human protocolNo general protocol established by this single study

What researchers measured

  • Primary: fasting blood glucose and 2-hour oral glucose tolerance test changes at week 52
  • Secondary: visceral adipose tissue change at week 52

Methods reported in this human study

Tesamorelin throughout
2 mg per day for 12 months
Tesamorelin then placebo
2 mg per day for 6 months, then placebo for 6 months
Placebo then tesamorelin
Placebo for 6 months, then 2 mg per day for 6 months

The registry arm descriptions report study periods. They do not establish a regimen for a different population or product formulation.

Source checked 2026-09-28. This snapshot is not automatically updated.

Open original source (NCT00608023) ↗

Search all original studies on Tesamorelin → · Open Mix Chart →

See broader research collection status